Efficacy and Safety of LP-005 Injection in Patients With Complement-Mediated Kidney Disease
Efficacy and Safety of LP-005 Injection in Patients With Complement-Mediated Kidney Disease
Not yet recruiting · NCT07363265 · Registry updated 2026-01-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of LP-005 Injection in Patients With Complement-Mediated Kidney Disease | Complement-mediated Renal Diseases | Not yet recruiting | Phase 2 | 2026-01-23 | NCT07363265 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Longbio Pharma | 8 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Peking University First Hospital | Beijing | China | 72 |